Breast cancer has become the most commonly diagnosed cancer globally. The relapse and
metastasis of breast cancer remain a great challenge despite advances in chemotherapy …

Breast cancer is one of the leading causes of death in women. With improvements in early-
stage diagnosis and targeted therapies, there has been an improvement in the overall …

The ability to exploit the immune system as a weapon against cancer has revolutionised the
treatment of cancer patients, especially through immune checkpoint inhibitors (ICIs) …

Purpose: Despite promising advances in breast cancer immunotherapy, augmenting T-cell
infiltration has remained a significant challenge. Although neither individual vaccines nor …

The characterization of tumor antigens recognized by immune effector cells has opened the
perspective of developing therapeutic vaccines in the field of breast cancer. The potential …

Clinical progress in the field of HER2-positive breast cancer therapy has been dramatically
improved by understanding of the immune regulatory mechanisms of tumor …

Decades of research are now leading to therapeutics that target the molecular mechanisms
of the cancer-specific immune response. These therapeutics include tumor antigen …

Breast cancer is immunogenic, and infiltrating immune cells in primary breast tumors convey
important clinical prognostic and predictive information. Furthermore, the immune system is …

Breast cancer is the most commonly diagnosed cancer among women. Therapeutic
treatments for breast cancer generally include surgery, chemotherapy, radiotherapy …

The immune system plays a major role in cancer surveillance. Harnessing its power to treat
many cancers is now a reality that has led to cures in hopeless situations where no other …